Episode
From Bedside to Boardroom: How AI, Multi-Omics, and New Business Models Are Shaping the Biomedical Frontier with Morgan Cheatham
- Podcast
- NEJM AI Grand Rounds
- Published
- Mar 19, 2025
- Duration seconds
- 3502
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/nejm-ai-grand-rounds-5875765/episodes/from-bedside-to-boardroom-how-ai-multi-omics-and-new-business-models-are-shaping-the-biomedical-frontier-with-morgan-cheatham/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/nejm-ai-grand-rounds-5875765/from-bedside-to-boardroom-how-ai-multi-omics-and-new-business-models-are-shaping-the-biomedical-frontier-with-morgan-cheatham.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Morgan Cheatham joins hosts Raj Manrai and Andy Beam on NEJM AI Grand Rounds to discuss the evolving landscape of artificial intelligence in health care, from its role in automating clinical documentation to its transformative potential in genomic medicine. A venture capitalist and future physician, Morgan shares how his background in computational decision sciences led him to medical school and investing, offering insights into how AI is reshaping everything from disease phenotyping and clinical decision-making to scaling precision medicine. He reflects on his work evaluating ChatGPT’s performance on the USMLE, the growing importance of genomic learning health systems, and why the biggest challenge isn’t technological innovation—but aligning payment models to support AI-driven advancements in medicine. Transcript.